AF
MYGN icon

Allworth Financial’s Myriad Genetics MYGN Stock Holding History

Allworth Financial’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Buy
4,335
+1,824
+73% +$8.28K ﹤0.01% 3026
2026
Q1 		$11.3K Sell
2,511
-219
-8% -$1.14K ﹤0.01% 3418
2025
Q4 		$16.8K Buy
2,730
+1,108
+68% +$8.03K ﹤0.01% 2923
2025
Q3 		$11.7K Buy
1,622
+1,012
+166% +$6.01K ﹤0.01% 3039
2025
Q2 		$3.24K Buy
610
+238
+64% +$1.41K ﹤0.01% 3494
2025
Q1 		$2.74K Sell
372
-25
-6% -$300 ﹤0.01% 3073
2024
Q4 		$4.88K Buy
397
+382
+2,547% +$7.05K ﹤0.01% 2776
2024
Q3 		$411 Hold
15
– – ﹤0.01% 3463
2024
Q2 		$390 Hold
15
– – ﹤0.01% 3435
2024
Q1 		$320 Hold
15
– – ﹤0.01% 3384
2023
Q4 		$288 Sell
15
-38
-72% -$657 ﹤0.01% 3244
2023
Q3 		$851 Buy
+53
New +$1.01K ﹤0.01% 2899
2022
Q2 		– Sell
-9
Closed – – 2651
2022
Q1 		$0 Buy
+9
New +$230 ﹤0.01% 2278
2015
Q4 		– Sell
-286
Closed -$11K – 645
2015
Q3 		$11K Hold
286
– – ﹤0.01% 381
2015
Q2 		$10K Hold
286
– – ﹤0.01% 386
2015
Q1 		$10K Buy
+286
New +$10.2K ﹤0.01% 397

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allworth Financial's MYGN Position: Q2 2026 in Review

Allworth Financial increased its Myriad Genetics (MYGN) stake by 73% in Q2 2026, buying an estimated $8.28K and bringing the position to 4,335 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3026.

Allworth Financial first reported a position in MYGN in Q1 2015 and has held it in 16 quarters since. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Allworth Financial held 4,335 shares of Myriad Genetics worth $24.8K as of Q2 2026.
  • Allworth Financial bought 1,824 Myriad Genetics shares in Q2 2026, an estimated $8.28K.
  • Myriad Genetics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3026 holding.
  • Allworth Financial first reported a position in Myriad Genetics in Q1 2015 and has held it in 16 quarters since.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.